Loading clinical trials...
Loading clinical trials...
Phase II Multi-institutional Proof of Concept Single-arm Trial of Nivolumab in the Treatment of Patients With Platinum Recurrent or Refractory Metastatic Germ Cell Tumors
Conditions
Interventions
Nivolumab
Locations
1
Portugal
Hospital Beatriz Ângelo
Loures, Portugal
Start Date
October 1, 2018
Primary Completion Date
June 30, 2019
Completion Date
June 30, 2019
Last Updated
August 21, 2019
NCT04283773
NCT01055067
NCT02390843
NCT02161692
Lead Sponsor
Hospital Beatriz Ângelo
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions